Comparing surgery types for lung cancer after pre-surgery therapy
Part of Cancer, Lungs & breathing clinical trials.
This trial compares different surgical methods (robotic, VATS, or open surgery) used to remove lung cancer after patients have had chemotherapy and/or immunotherapy before their operation. It looks at results from five specialized hospitals to help understand which approach may work best.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have non-small cell lung cancer (NSCLC) at a certain stage (IIB or III).
- You had surgery to remove the cancer between January 2016 and March 2024.
- Before surgery, you received chemotherapy combined with immunotherapy or immunotherapy alone.
- You were at least 18 years old at the time of your surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two types of lung cancer surgery—removing just the tumor section (segmentectomy) or the whole lobe (lobectomy)—done through small cuts (minimally invasive). The goal is to see which approach leads to better daily living and recovery for early-stage lung cancer patients.
This study compares two different ways of doing robotic lung surgery to remove cancer. It looks at whether using one method (with an extra opening) is better than the standard method for people with early-stage lung cancer that can be removed.
This study compares two types of lung cancer surgery for early-stage tumors: removing only the part of the lung with the tumor (segmentectomy) versus removing the entire lobe (lobectomy). It aims to see if the smaller surgery works just as well and might be easier to recover from.
This trial tests whether combining chemo or targeted therapy before surgery can help people with non-small cell lung cancer that may require removing a whole lung. We want to see if this approach makes the surgery safer and more effective.
This study compares two types of lung surgery for early-stage lung cancer: removing only the tumor part (segmentectomy) versus removing a larger portion (lobectomy). The goal is to see if the less invasive surgery works just as well while preserving more healthy lung tissue.
This trial looks back at medical records to compare different ways of performing a segmentectomy (removing a small part of the lung) for early-stage lung cancer. It aims to see which approach might lead to better outcomes for patients like you.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.